Superdrug launches COVID-19 antibody test

Superdrug has launched a COVID-19 antibody blood test, available through its online doctor service.

SD_testkit%20%281%29%20resziwe.png
Patients can collect a blood sample at home, and send the test off for processing in a laboratory.

The COVID-19 antibody home sampling kit, which costs £69 and is on sale from today (May 20), analyses a blood sample provided by the patient to test whether they have had COVID-19 in the past and have recovered.

The blood sample must be taken at least 14 days after a patient has presented with COVID-19 symptoms, or it can be used at any time if an individual has never experienced symptoms.

The sample is then sent back to an accredited lab for processing, with the results available in two to three days.

The multiple said today that “all of the components of the home sampling test kits are CE marked and the test run by a United Kingdom Accreditation Service-accredited laboratory”.

A CE mark is granted to a product when it has been deemed safe for use by European Economic Area standards.

The tests will only be available online, via Superdrug’s online doctor service and customers will not be able to purchase them in-store.

Superdrug claims the test “has a sensitivity of 97.5%” and that it “has a specificity of 100%, which means it will not give you a positive result if you do not have coronavirus antibodies”.

Superdrug healthcare director Michael Henry, said the test is Public Health England certified and provides an “accessible way for people to know whether they have already been infected with COVID-19”.

However, Superdrug’s doctor ambassador Dr Zoe Williams stressed that testing positive for having had the virus “does not confer immunity”.

“It is important that people understand [that] a positive test result does not mean you can be any more relaxed with the required hygiene and social distancing measures set out by the government,” she added.

Sign in or register for free

Latest from News

CPE ‘reluctantly accepted’ funding offer amid ‘impossible position’

 
• By 
 • comment

Community Pharmacy England (CPE) has said that it “reluctantly accepted the final offer” of the long-awaited pharmacy funding deal, stressing that it is “not enough” to stabilise the sector.

New contract: NPA to ‘consult’ members on collective action

 
• By 
 • comment

The NPA has said that it will “consult” its members on whether collective action will go ahead from tomorrow following the government’s announcement of a £3 billion funding deal for 2025/26.

‘CPE is falling into a trap’ - pharmacy reacts to funding deal

 
• By 
 • comment

C+D rounds up the immediate reaction to the new CPCF funding contract from pharmacy trade bodies, politicians, and the CPE negotiating team.

More from Multiples